Delivery Order SPE2DB22D2206-SPE2DB24FJE14
Award Date
7/12/24
Potential Completion Date
8/2/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a Firm Fixed Price of $3,230.68. The contract has an ultimate completion date of August 5, 2024 and was awarded on July 15, 2024. This award is a Delivery Order issued under Amerisourcebergen's...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $9,391.86, with a firm fixed price. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The $4,845.99 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and was awarded on November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,677.52 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 27, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The $17,061.84 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that is registered in the System for Award Management (SAM.gov) through June 2025. The contract has an ultimate completion date of August 17, 2023 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,310.64 and a period of performance through October 19, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Envarsus XR 4 mg tablets. The $1,615.33 firm fixed-price delivery order has an ultimate completion date of October 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award, valued at $4,181.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Envarsus XR 4 mg tablets, a specialty medication, to support military healthcare programs globally. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The $6,461.32 firm-fixed price contract was awarded on April 24, 2024 to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, with a period of performance through May 15, 2024. The contract is not designated as a set-aside and was awarded under a larger Indefinite Delivery...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,099.26, is for the delivery of Envarsus XR 1 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to...